Cited by 511Barrier Structure and Function StudiesCerebrospinal fluid and hydrocephalusDrug Transport and Resistance Mechanisms

The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.

CSF, blood-brain barrier, and brain drug delivery

Pardridge, William M.·2016·Expert Opinion on Drug Delivery

DOI 10.1517/17425247.2016.1171315

Open this paper in CoChat — free account

Abstract

INTRODUCTION: There are 2 misconceptions about the cerebrospinal fluid (CSF), the blood-brain barrier (BBB), and brain drug delivery, which date back to the discovery of a barrier between blood and brain over 100 years ago. Misconception 1 is that drug distribution into CSF is a measure of BBB transport. Misconception 2 is that drug injected into the CSF compartment distributes to the inner parenchyma of brain. AREAS COVERED: Drug distribution into the CSF is a function of drug transport across the choroid plexus, which forms the blood-CSF barrier, and not drug transport across the BBB, which is situated at the microvascular endothelium of brain. Drug injected into CSF undergoes rapid efflux to the blood compartment via bulk flow. Drug penetration into brain parenchyma from the CSF is limited by diffusion and drug concentrations in brain decrease exponentially relative to the CSF concentration. EXPERT OPINION: The barrier between blood and brain was discovered in 1913, when it was believed that the BBB was localized to the choroid plexus, and that nutrient flow from blood passed through the CSF en route to brain. These misconceptions are still widely held, and hinder progress in the development of technology for BBB drug delivery.

Integrity signals

Registry

Crossref · 10.1517/17425247.2016.1171315

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

null
null (2016) · Philosophy Study · doi:10.17265/2159-5313/2016.09.003 · Cited by 28,317
A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β
Iliff, J. J., Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., Vates, G. E., Deane, R., Goldman, S. A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003748 · Cited by 5,824
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,776
JUNCTIONS BETWEEN INTIMATELY APPOSED CELL MEMBRANES IN THE VERTEBRATE BRAIN
Brightman, M., & Reese, T. S. (1969) · The Journal of Cell Biology · doi:10.1083/jcb.40.3.648 · Cited by 2,457
The Permeability of Capillaries in Various Organs as Determined by Use of the ‘Indicator Diffusion’ Method
Crone, C. (1963) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1963.tb02652.x · Cited by 1,157
Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study.
Butt, A. M., Jones, H. C., & Abbott, N. J. (1990) · The Journal of Physiology · doi:10.1113/jphysiol.1990.sp018243 · Cited by 775
Evidence for a ‘Paravascular’ fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space
Rennels, M. L., Gregory, T. F., Blaumanis, O. R., Fujimoto, K., & Grady, P. A. (1985) · Brain Research · doi:10.1016/0006-8993(85)91383-6 · Cited by 752
Principles of neural science
de Jong, J. M. B. V. (1986) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(86)90083-3 · Cited by 666
Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization.
Pardridge, W. M., Boado, R. J., & Farrell, C. R. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)38267-x · Cited by 606
Self-citation
Radioimmunotherapy of human tumours
Larson, S. M., Carrasquillo, J. A., Cheung, N. V., & Press, O. W. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3925 · Cited by 540

Show all 88 references

Research works printed but not linked: 11

Verrees M, 2004, Am Fam Physician, 70, 1071
Poplack DG, 1977, Cancer Res, 37, 1982
Brightman MW, 1993, The blood-brain barrier, 107
Anderson JM, 2001, News Physiol Sci, 16, 126
Reiber H, 2003, Restor Neurol Neurosci, 21, 79
Pardridge WM, 1985, Am J Physiol, 249, E534
Covell DG, 1985, Am J Physiol, 248, R147
10.17265/2159-5313/2016.09.003 · DOI · Paper page
Morrison PF, 1994, Am J Physiol, 266, R292
Cserr HF, 1981, Am J Physiol, 240, F319
Zhang X, 1998, Neurosci, 4, 1225

Sorted by citations

Items 301–400 of 511

Biodistribution of Adeno-Associated Virus Serotype 5 Viral Vectors Following Intrathecal Injection
Pflepsen, K. R., Peterson, C. D., Kitto, K. F., Riedl, M. S., McIvor, R. S., Wilcox, G. L., Vulchanova, L., & Fairbanks, C. A. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00252 · Cited by 10
Inhibiting CK2 among Promising Therapeutic Strategies for Gliomas and Several Other Neoplasms
Pucko, E. B., & Ostrowski, R. P. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020331 · Cited by 10
Understanding central nervous system fluid networks: Historical perspectives and a revised model for clinical neurofluid imaging
Mehta, R. I., & Mehta, R. I. (2024) · NMR in Biomedicine · doi:10.1002/nbm.5149 · Cited by 9
Exploring How Antibody Format Drives Clearance from the Brain
Schwinghamer, K., Kopec, B. M., Ayewoh, E. N., Tao, X., Sadekar, S., Sreedhara, A., Kelley, R. F., Tesar, D. B., & Siahaan, T. J. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00354 · Cited by 10
Advances in the Repurposing and Blood–Brain Barrier Penetrance of Drugs in Pediatric Brain Tumors
Rechberger, J. S., Toll, S. A., Biswas, S., You, H. B., Chow, W. D., Kendall, N. A. S., Navalkele, P. D., & Khatua, S. (2025) · Cancers · doi:10.3390/cancers17030439 · Cited by 12
Harnessing the circadian nature of the choroid plexus and cerebrospinal fluid
Fame, R. M. (2025) · npj Biological Timing and Sleep · doi:10.1038/s44323-025-00033-5 · Cited by 11
Nanobody-based radiotracers in nuclear medicine: Advances, challenges, and future perspectives
Yao, Y., Tian, J., Zhang, R., Liu, P., Gao, X., Zhou, W., & Luo, L. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.111517 · Cited by 9
An integrative neuropharmacological review of Huntington’s disease challenges and the role of novel formulations in addressing pharmacological‒pharmaceutical limitations
Senousy, M. A., Eid, A. H., Zaki, M. B., Abd‐Elmawla, M. A., Ghaiad, H. R., El‐Shiekh, R. A., Ahmed, S., & Khalifa, H. O. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1794983 · Cited by 9
Cerebral Apolipoprotein D Exits the Brain and Accumulates in Peripheral Tissues
Desmarais, F., Hervé, V., Bergeron, K., Ravaut, G., Perrotte, M., Fyfe-Desmarais, G., Rassart, É., Ramassamy, C., & Mounier, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084118 · Cited by 9
Unraveling the tau puzzle: a review of mechanistic targets and therapeutic interventions to prevent tau pathology in Alzheimer’s disease
Kammula, S. V., Tripathi, S., Wang, N., Dawson, V. L., Dawson, T. M., & Mao, X. (2023) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2023.20 · Cited by 9
Predicting the pharmacokinetics and pharmacodynamics of antisense oligonucleotides: an overview of various approaches and opportunities for PBPK/PD modelling
Gao, X., Diep, J. K., Norris, D. A., Yu, R. Z., & Geary, R. S. (2023) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2023.2283524 · Cited by 9
Bioinspired Approaches for Central Nervous System Targeted Gene Delivery
Kumar, J., Karim, A., Sweety, U. H., Sarma, H., Nurunnabi, M., & Narayan, M. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00842 · Cited by 9
Optimal timing for drug delivery into the hippocampus by focused ultrasound: A comparison of hydrophilic and lipophilic compounds
Seo, Y., Chang, K. W., Lee, J., Kong, C., Shin, J., Chang, J. W., Na, Y. C., & Chang, W. S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29480 · Cited by 9
Nanoengineered biomaterials for spinal cord regeneration
Assunção-Silva, R. C., Gomes, E. D., Silva, N. A., & Salgado, A. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813355-2.00008-9 · Cited by 9
Pharmacokinetics and absolute oral bioavailability of stemazole by UPLC–MS/MS and its bio‐distribution through tritium labeling
Li, H., Tan, Q., Zhang, Y., Zhang, J., Zhao, C., Lu, S., Qiao, J., & Han, M. (2019) · Drug Testing and Analysis · doi:10.1002/dta.2694 · Cited by 9
Periphery-confined particulate systems for the management of neurodegenerative diseases and toxicity: Avoiding the blood-brain-barrier challenge
Rabanel, J., Delbreil, P., Banquy, X., Brambilla, D., & Ramassamy, C. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.03.035 · Cited by 10
Pathophysiology of the choroid plexus in brain diseases
Mihaljević, S., Michalicová, A., Bhide, M., & Kováč, A. (2021) · General Physiology and Biophysics · doi:10.4149/gpb_2021032 · Cited by 9
Alpha4 beta7 integrin controls Th17 cell trafficking in the spinal cord leptomeninges during experimental autoimmune encephalomyelitis
Rossi, B., Dusi, S., Angelini, G., Bani, A., Lopez, N., Bianca, V. D., Pietronigro, E. C., Zenaro, E., Zocco, C., & Constantin, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1071553 · Cited by 13
Lumbar Intrathecal Injection in Adult and Neonatal Mice
Stavrou, M., Georgiou, E., & Kleopa, K. A. (2024) · Current Protocols · doi:10.1002/cpz1.1091 · Cited by 8
Blood-brain barriers and drug pharmacokinetics: mechanisms and models
Tregub, P. P., Bystrov, D. A., Kushnir, I. A., Korsakova, S. A., Yurchenko, S. O., & Salmina, A. B. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177872 · Cited by 9
Intranasal delivery route for neurodegenerative diseases: recent insights and future directions
Correale, J. D., Mattera, V. S., & Pasquini, J. M. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01919-4 · Cited by 10
Nanoparticles Navigating the Intranasal Route: Innovative Approaches in Neurodegenerative Diseases
Borbolla‐Jiménez, F. V., Gutiérrez-Ruíz, S. C., Hernández‐Parra, H., Peña‐Corona, S. I., Tamez-González, A., Rivas-Amores, R. D., Magaña, J. J., & Leyva‐Gómez, G. (2025) · Journal of Nanotechnology · doi:10.1155/jnt/7697122 · Cited by 7
Quantum dots in neurotheranostics for the treatment of Alzheimer’s disease
Sharma, T., Bashir, B., Sharma, P., andotra, N., Singh, S. K., Singh, T. G., & Vishwas, S. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102876 · Cited by 9
The brain-joint axis: links between osteoarthritis and neurodegenerative disorders in aging
Rabie, M. A., Madry, H., Cucchiarini, M., & Sayed, N. S. E. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.10.023 · Cited by 13
Small Extracellular Vesicles from Neural Cells: Physiological and Pathological Roles, and Potential in Neurodegenerative Therapy
Salim, M. W., Zhang, W., Collins‐Praino, L. E., Wang, Y., & Care, A. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202504608 · Cited by 8
Strategies to Improve Insulin Delivery through Oral Route: A Review
Gangadharappa, H. V., Bhattacharya, R., Johnson, A. P., Shailesh, T., & Rahamathulla, M. (2021) · Current Drug Delivery · doi:10.2174/1567201818666210720145706 · Cited by 9
Cattle Encephalon Glycoside and Ignotin Reduce Early Brain Injury and Cognitive Dysfunction after Subarachnoid Hemorrhage in Rats
Ma, K., Li, R., Zhao, H., Qu, J., Mu, N., Liu, X., Shi, W., Yang, C., Feng, H., Tan, L., et al. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.07.022 · Cited by 8
Oligonucleotides: A novel area of interest for drug delivery in neurodegenerative diseases
Alharbi, K. S., Shaikh, M. A. J., Afzal, O., Altamimi, A. S. A., Almalki, W. H., Kazmi, I. A., Al-Abbasi, F. A., Alzarea, S. I., Babu, M. R., Singh, S. K., et al. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103849 · Cited by 8
Physiologically Based Pharmacokinetic Model of Brain Delivery of Plasma Protein Bound Drugs
Pardridge, W. (2023) · Pharmaceutical Research · doi:10.1007/s11095-023-03484-2 · Cited by 7
Self-citation
Changes in blood–brain barrier permeability characterized from electroencephalograms with a combined wavelet and fluctuation analysis
Павлов, А. Н., Khorovodov, A. P., Mamedova, A., Koronovskii, A. A., Pavlova, O. N., SEMYACHKINA-GLUSHKOVSKAYA, O. V., & Kurths, J. (2021) · The European Physical Journal Plus · doi:10.1140/epjp/s13360-021-01593-8 · Cited by 8
Investigation of factors affecting students' satisfaction with online course components.
Qureshi, E. (2004) · Scholarship at UWindsor (University of Windsor) · Cited by 8
Pronociceptive role of spinal Cav2.3 (R‐type) calcium channels in a mouse model of postoperative pain
Ferreira, M. D. A., Lückemeyer, D. D., Martins, F., Schran, R. G., da Silva, A. M., Gambeta, E., Zamponi, G. W., & Ferreira, J. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16407 · Cited by 7
Navigating neurodegeneration: challenges, pathophysiology, biomarkers, and the promise of nanocrystals-based nanotherapeutics
Kaur, G., Dewangan, J. P., Kumari, A. R., & Shukla, R. (2025) · Journal of Microencapsulation · doi:10.1080/02652048.2025.2507637 · Cited by 7
Liposomes: Production Methods and Application in Alzheimer’s Disease
Naziris, N., & Demetzos, C. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-78787-5_48 · Cited by 7
Lipid mediator n‐3 docosapentaenoic acid‐derived protectin D1 enhances synaptic inhibition of hippocampal principal neurons by interaction with a G‐protein‐coupled receptor
Mikroulis, A. V., Ledri, M., Ruffolo, G., Palma, E., Sperk, G., Dalli, J., Vezzani, A., & Kokaia, M. (2022) · The FASEB Journal · doi:10.1096/fj.202101815r · Cited by 7
Amphiphilic Endomorphin-1 Derivative Functions as Self-assembling Nanomedicine for Effective Brain Delivery
Liu, H., Zhao, X., Liang, S., Fan, L.-L., Li, Z., Zhang, Y., & Ni, J. (2019) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c19-00250 · Cited by 7
Using the LeiCNS-PK3.0 Physiologically-Based Pharmacokinetic Model to Predict Brain Extracellular Fluid Pharmacokinetics in Mice
Saleh, M. A. A., Gülave, B., Campagne, O., Stewart, C. F., Elassaiss‐Schaap, J., & de Lange, E. C. M. (2023) · Pharmaceutical Research · doi:10.1007/s11095-023-03554-5 · Cited by 6
MRI-Guided Focused Ultrasound in Parkinson’s Disease and Essential Tremor: Incisionless but Invasive. A Narrative Review
Metta, V., Benamer, H. T. S., Kapsas, G., Mridula, R., Alugolu, R., Hussain, H., Nalarakettil, A., Sai, S., Elmahdy, M., Borgohain, R., et al. (2025) · Journal of Movement Disorders · doi:10.14802/jmd.25042 · Cited by 6
Natural polysaccharides in colloidal drug delivery systems for brain glioma therapy: Mechanisms and advancements
Li, C., Ma, W., Shen, H., Hou, Z., Chen, J., Yang, L., & Sun, W. Y. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.115059 · Cited by 7
Antisense oligonucleotide therapy mitigates autosomal dominant progressive hearing loss in a murine model of human DFNA2
Jang, S. H., Roh, J. W., Oh, K. S., Joo, S. Y., Kim, J. A., Kim, S. J., Choi, J. Y., Jung, J., Kim, Y., Bok, J., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.08.044 · Cited by 7
Affinity-based drug delivery systems for the central nervous system: exploiting molecular interactions for local, precise targeting
Ferrer, P. R., & Sakiyama‐Elbert, S. E. (2024) · Journal of Neural Engineering · doi:10.1088/1741-2552/ad680a · Cited by 6
Polymeric Nanoparticles Revolutionizing Brain Cancer Therapy: A Comprehensive Review of Strategies and Advances
Wahengbam, G. S., Nirmal, S., Nandwana, J., Kar, S., Kumari, V., Mishra, R., & Singh, A. (2024) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2024051822 · Cited by 7
Human Amyloid-β40 Kinetics after Intravenous and Intracerebroventricular Injections and Calcitriol Treatment in Rats In Vivo
Peng, H., Noh, K., Pan, S. R., Saldivia, V., Serson, S., Toscan, A., de Lannoy, I. A. M., & Pang, K. S. (2020) · Drug Metabolism and Disposition · doi:10.1124/dmd.120.090886 · Cited by 8
A Human Neurovascular Unit On-a-Chip
Lee, S. W. L., Rogosic, R., Venturi, C., Raimondi, M. T., Pavesi, A., & Adriani, G. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1693-2_7 · Cited by 6
Analysis of Key Factors Associated with Response to Salvage High-Dose Methotrexate Rechallenge in Primary Central Nervous System Lymphoma with First Relapse
Du, P., Chen, H., Shen, L., Liu, X., Wu, X., Chen, L., Cao, A., & Geng, D. (2022) · Current Oncology · doi:10.3390/curroncol29090522 · Cited by 6
Music improves the therapeutic effects of bevacizumab in rats with glioblastoma: Modulation of drug distribution to the brain
SEMYACHKINA-GLUSHKOVSKAYA, O. V., Diduk, S., Anna, E., Elina, D., Artem, K., Khorovodov, A. P., Shirokov, A. A., Fedosov, I. V., Dubrovsky, A. I., Андреевна, Б. И., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1010188 · Cited by 6
Phytoconstituents-based nanoformulations for neurodegenerative disorders
Rajput, M. S., Nirmal, N. P., Patel, V. A., Sarkar, P. D., & Raval, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-19143-5.00003-7 · Cited by 6
Central Nervous System Drug Delivery After Ischemic or Hemorrhagic Stroke
Hoang, N., & Nimjee, S. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813997-4.00024-4 · Cited by 7
Leptomeningeal metastases from solid tumours
Höfer, S., & Rhun, É. L. (2021) · memo - Magazine of European Medical Oncology · doi:10.1007/s12254-021-00693-6 · Cited by 6
Nanotechnology at the Rescue of Neurodegenerative Diseases: Tools for Early Diagnostic
Rabanel, J., Perrotte, M., & Ramassamy, C. (2019) · Springer eBooks · doi:10.1007/978-3-030-30930-5_2 · Cited by 6
Breaking the brain barrier: Hybrid nanoparticle-enabled delivery for next-gen neurotherapeutics
Dargude, S., Chabukswar, A. R., & Jagdale, S. C. (2025) · Hybrid Advances · doi:10.1016/j.hybadv.2025.100513 · Cited by 6
The application of mesenchymal stem cells in the treatment of traumatic brain injury: Mechanisms, results, and problems.
Zhang, Y., Zheng, Z., Sun, J., Xu, S., Wei, Y., Ding, X. H., & Ding, G. (2024) · PubMed · doi:10.14670/hh-18-716 · Cited by 5
Intrathecal rituximab in immunoglobulin G4-hypertrophic pachymeningitis
Soares, C., Martins, D. F., Pestana-Silva, R., Honavar, M., Faria, O., Abreu, P., & da Costa, A. G. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.576997 · Cited by 5
Indirect SPECT Imaging Evaluation for Possible Nose-to-Brain Drug Delivery Using a Compound with Poor Blood–Brain Barrier Permeability in Mice
Mizutani, A., Kobayashi, M., Ohuchi, M., Sasaki, K., Muranaka, Y., Torikai, Y., Fukakusa, S., Suzuki, C., Nishii, R., Haruta, S., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14051026 · Cited by 5
Glucose Stimulates Glial Cell Line-Derived Neurotrophic Factor Gene Expression in Microglia through a GLUT5-Independent Mechanism
Aldhshan, M. S., Jhanji, G., Poritsanos, N. J., & Mizuno, T. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137073 · Cited by 4
Optimizing a therapy for opiate use disorders: Characterizing ondansetron pharmacokinetics in blood and brain
Wu, M., Cheng, Z., Le, A. T., Tan, Y., & Peltz, G. (2022) · Clinical and Translational Science · doi:10.1111/cts.13440 · Cited by 5
Boron Delivery to Brain Cells via Cerebrospinal Fluid (CSF) Circulation in BNCT of Brain-Tumor-Model Rats—Ex Vivo Imaging of BPA Using MALDI Mass Spectrometry Imaging
Kusaka, S., Miyake, Y., Tokumaru, Y., Morizane, Y., Tamaki, S., Akiyama, Y., Sato, F., & Murata, I. (2022) · Life · doi:10.3390/life12111786 · Cited by 5
Inorganic and metal-based nanoparticles
Paul, G., Gupta, U., Shah, H., Mazahir, F., & Yadav, A. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91924-1.00006-x · Cited by 6
Preparation, characterisation, pharmacokinetics and distribution of esculin microspheres administered via intravitreal injection into rabbit brain
Wu, D., Luo, R. X., Chen, Y., Zheng, Z., Gui, S., & He, N. (2024) · Xenobiotica · doi:10.1080/00498254.2024.2341402 · Cited by 5
Diffusion assessment through image processing: beyond the point-source paradigm
Postnikov, E. B., Nаmykin, A. A., SEMYACHKINA-GLUSHKOVSKAYA, O. V., & Postnov, D. E. (2021) · The European Physical Journal Plus · doi:10.1140/epjp/s13360-021-01487-9 · Cited by 5
Synthesis of a Diapocynin Prodrug for Its Prolonged Release from Zwitterionic Biodegradable Nanoparticles
Auriemma, R., Sponchioni, M., Palmiero, U. C., Manfredini, N., Dinani, F. S. R., & Moscatelli, D. (2021) · Macromolecular Chemistry and Physics · doi:10.1002/macp.202100223 · Cited by 4
Proteins of the cancer cell secretome induce the protumoral microenvironment of diffuse intrinsic pontine glioma
Baulenas‐Farres, M., Paco, S., Marino, F., Mohr, J., Panisello, C., Balaguer‐Lluna, L., Aschero, R., Cuadrado‐Vilanova, M., Resa‐Pares, C., Rodríguez, E., et al. (2025) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaf132 · Cited by 4
Transient acute neuronal activation response caused by high concentrations of oligonucleotides in the cerebral spinal fluid
Bravo‐Hernández, M., Mazur, C., Chen, H., Fradkin, L., Searcy, J., Burel, S. A., Kelly, M., Bruening, D., O’Rourke, J. G., Cai, Y., et al. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag057 · Cited by 9
Navigating the Ethereal Tightrope: The Nanogenerator Manipulates Neurons for Immune Equilibrium
Du, J., Deng, R., Wu, Y., Ren, H., Lin, Z., & Miao, Y. (2026) · Advanced Science · doi:10.1002/advs.202512284 · Cited by 4
Ceftazidime/avibactam combined with colistimethate sodium successfully cures carbapenem-resistant Pseudomonas aeruginosa-induced brain abscess in a child post-craniotomy: a case report
Yuan, M., Zong, M., Ren, C., Zong, W., & Li, Z. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1444172 · Cited by 4
Self-assembling chemically modified siRNA nanorings for RNAi therapy and neuroprotection in Alzheimer’s disease
Jiang, Y., Li, L., Fang, X. J., Zeng, T., Su, L., Liu, Y., Wu, Y., Li, J., Lyu, P., Lu, Z., et al. (2025) · Science China Chemistry · doi:10.1007/s11426-024-2497-7 · Cited by 4
Predicting seizure liability of small molecules using an in vitro multi-electrode array based assay coupled with modeling of brain disposition
Belair, D. G., Kohnken, R. A., McCloud, R. L., Sandoval, S., Green, J., Buck, W. R., & Polakowski, J. S. (2025) · Current Research in Toxicology · doi:10.1016/j.crtox.2025.100236 · Cited by 4
Assessment of brain penetration and tumor accumulation of niraparib and olaparib: insights from multimodal imaging in preclinical models
Groseclose, M. R., Barry, J. A., Skedzielewski, T., Pang, Y., Li, Y., McDermott, G., Deutsch, J., Balabhadrapatruni, C., Benson, W., Lim, D., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-18255-9 · Cited by 4
Tau and Alzheimer’s Disease: Molecular Mechanisms and Treatment Approaches
Reiss, A. B., Muhieddine, D., Leon, A. Z. D., Voloshyna, I., Gomolin, I. H., & Pinkhasov, A. (2021) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-021-01092-y · Cited by 4
Measurement and Modeling of Transport Across the Blood–Brain Barrier
Fan, H., Cai, Q., & Qin, Z. (2023) · Journal of Biomechanical Engineering · doi:10.1115/1.4062737 · Cited by 4
Recent Advances in Drug Delivery Systems for Targeting the Blood-Brain Barrier
Sree Lakshmi, N. (2024) · Journal of Pharma Insights and Research. · doi:10.69613/3bw93d33 · Cited by 5
Ionic liquids and their potential use in development and improvement of drug delivery systems: evidence of their tendency to promote drug accumulation in the brain
Eades, W. C., Abdolmohammadpourbonab, S., Đinh, L., & Yan, B. (2024) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2024.2417004 · Cited by 5
Drug Delivery to the Brain Using Endocytic Receptors as Carriers
Talwar, P., Saha, P., Anjana Mohan, A., Divya, S., & Ravanan, P. (2025) · The Receptors · doi:10.1007/978-3-031-81991-9_19 · Cited by 4
Influence of transporters in treating cancers in the CNS
Gampa, G., Talele, S., Kim, M., Mohammad, A. S., Griffith, J. I. G., & Elmquist, W. F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816434-1.00009-7 · Cited by 4
A Review of Mathematics Determining Solute Uptake at the Blood–Brain Barrier in Normal and Pathological Conditions
Sprowls, S. A., Saralkar, P. A., Arsiwala, T. A., Adkins, C. E., Blethen, K. E., Pizzuti, V. J., Shah, N., Fladeland, R. A., & Lockman, P. R. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13050756 · Cited by 4
Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice
Liou, C.-W., Yao, T.-H., & Wu, W.-L. (2022) · Journal of Visualized Experiments · doi:10.3791/63972 · Cited by 5
Protein Drug Delivery Using a Novel Maxillofacial Technique Targeting the Visual Pathway in the Brain, the Optic Nerve, and the Retina
Rajendran, R., Arunachalam, J. P., Chidambaram, S., Srikanth, K., Krishnamurthy, B., Vinayagam, S., Veeravarmal, V., Prasad, H., Verma, K., & Anoop, U. R. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00184 · Cited by 4
Transporter Systems and Metabolism at the Blood–Brain Barrier and Blood–CSF Barrier
Verma, K., Kapoor, D. U., Jain, S., Singh, R., & Sharma, S. K. (2023) · Springer eBooks · doi:10.1007/978-981-99-6807-7_3 · Cited by 4
Intrathecal sc-AAV9-CB-GFP: Systemic Distribution Predominates Following Single-Dose Administration in Cynomolgus MacaquesPreprint
Meseck, E. K., Guibinga, G.-H., Wang, S. H., McElroy, C., Hudry, E., & Mansfield, K. G. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.28.470258 · Cited by 4
Blood and cerebrospinal fluid flow oscillations measured with real-time phase-contrast MRI: breathing mode mattersPreprint
Laganà, M. M., Tella, S. D., Pelizzari, L., Cazzoli, M., Alperin, N. J., Jin, N., Zacà, D., Baselli, G., & Baglio, F. (2022) · Research Square · doi:10.21203/rs.3.rs-1722506/v1 · Cited by 4
Transient Acute Neuronal Activation Response Caused by High Concentrations of Oligonucleotides in the Cerebral Spinal FluidPreprint
Hernandez, M. B., Mazur, C., Chen, H., Fradkin, L., Searcy, J., Burel, S. A., Kelly, M. E., Bruening, D., O’Rourke, J. G., Cai, Y., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.13.638138 · Cited by 4
Pharmacokinetic approaches to standardize antiviral exposure in cerebrospinal fluid
Avedissian, S. N., Mu, Y., McCarthy, C., Bosch, R. J., Spudich, S., Gandhi, R. T., McMahon, D. K., Eron, J. J., Mellors, J. W., Liu, J., et al. (2025) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.70013 · Cited by 3
Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats
Boitnott, A., Rioux, M., Chen, X., & Gray, S. J. (2025) · Journal of Visualized Experiments · doi:10.3791/67138 · Cited by 3
Genetic therapies for neurological diseases
Rahim, A. A., Kurian, M. A., Zhou, H., Ferguson, R., Tabrizi, S. J., Lignani, G., Aquilina, K., & Waddington, S. N. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100093 · Cited by 4
Targeting Hyaluronic Acid Increases Brain Retention of Intraventricular Dosed Antibodies in Mice
Schwinghamer, K., Siahaan, T. J., Sreedhara, A., Boswell, C. A., Mandikian, D., & Tesar, D. B. (2026) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00956 · Cited by 3
Nanomedicine for neuroinflammation modulation: Next-generation nano-immunotherapies for neurodegenerative disorders
Dhar, I., Bhatt, S., Gupta, S., Singh, S. K., & Dadhich, A. (2026) · Next Nanotechnology · doi:10.1016/j.nxnano.2026.100557 · Cited by 3
A Physiologically-Based Pharmacokinetic Model of the Brain Considering Regional Lipid Variance
Heitman, A., Bies, R. R., & Schwartz, S. L. (2022) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001256 · Cited by 3
Development of a Versatile High-through-put Oligonucleotide LC–MS Method to Accelerate Drug Discovery
Yun, C., Woo, H. C., Lovatt, D., Parish, C. A., Spellman, D. S., & Shen, H. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02934-3 · Cited by 3
Metabolic mechanisms of development and compensation of osmotic stress in the brain
Pigarova, E. A., & Dzeranova, L. K. (2017) · Obesity and metabolism · doi:10.14341/omet2017473-76 · Cited by 3
Air Pollution and the Nervous System: Diseases of the Brain Caused by Air Pollutants and Air Pollution
Lenzi, G., & Bonsanto, F. (2017) · Springer eBooks · doi:10.1007/978-3-319-62731-1_15 · Cited by 3
Drug Delivery to Primary and Metastatic Brain Tumors: Challenges and Opportunities
Talele, S., Mohammad, A. S., Schulz, J., Bauer, B., Hartz, A. M. S., Sarkaria, J. N., & Elmquist, W. F. (2022) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-030-88773-5_24 · Cited by 3
Neostigmine and atropine as a treatment for postdural puncture headache after spinal anesthesia in cesarean section: A case report
Shrestha, I. K., Chalise, R., Poudel, S., Regmi, A., Ghimire, A., Khadka, B., & Khanal, K. (2023) · Clinical Case Reports · doi:10.1002/ccr3.8132 · Cited by 4
The Significance of the Choroid Plexus for Cerebral Iron Homeostasis
Routhe, L. G., Thomsen, M. S., & Moos, T. (2020) · Physiology in health and disease · doi:10.1007/978-1-0716-0536-3_5 · Cited by 3
Diagnostic and theranostic intranasal nanointerventions for brain diseases
Upadhaya, P. G., Pulakkat, S., & Patravale, V. B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00013-8 · Cited by 4
Building Team Medicine in the Management of CNS Metastases
Baskaran, A. B., Buerki, R. A., Khan, O. H., Gondi, V., Stupp, R., Lukas, R. V., & Villaflor, V. M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12123901 · Cited by 3
Population Pharmacokinetic Modeling of Free Plasma and Free Brain Concentrations of Ceftaroline in Healthy and Methicillin-Resistant Staphylococcus aureus-Infected Wistar Rats
Helfer, V. E., Dias, B. B., Lock, G. D. A., Tomaszewski, C. A., Barnet, L. S., Barreto, F., Zavascki, A. P., de Araújo, B. V., & Costa, T. D. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00382-23 · Cited by 3
Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine stormPreprint
Yang, H., George, S. J., Thompson, D., Silverman, H. A., Tsaava, T., Tynan, A., Pavlov, V. A., Chang, E. H., Andersson, U., Brines, M. L., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1493296/v1 · Cited by 3
Multispecies minimal physiologically based pharmacokinetic-pharmacodynamic model of antisense oligonucleotides for central nervous system disorders
Desai, D. A., Ette, M. E., Shah, D. K., & Mager, D. E. (2025) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2025.100167 · Cited by 2
Intracerebral Distribution of Drugs with Diverse Blood–brain Barrier Transport Characteristics: In vivo Analysis using Brain Microdialysis in Cynomolgus Monkeys
Fujita, T., Kamikozawa, Y., Ozawa, M., Tajima, Y., Kurosawa, T., Katagiri, Y., Kawaguchi, H., Kakuuchi, A., Miyamoto, R., Wakayama, K., et al. (2025) · Pharmaceutical Research · doi:10.1007/s11095-025-03993-2 · Cited by 2
Development and characterisation of a thermoreversible sol–gel for intranasal delivery of MRI and PET imaging agents
Almahmoud, A., Parekh, H. S., Paterson, B. M., Tupally, K. R., Cowin, G., Nguyen, A. D., Gulzar, A., & Vegh, V. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126517 · Cited by 2

Authors: Pardridge, W. M.
Affiliations: University of California, Los Angeles (US)
Corresponding author: Pardridge, William M.
ORCID: Pardridge, William M.
Venue: Expert Opinion on Drug Delivery
Publisher: Informa UK Limited
Published: 2016-04-11
Volume: 13
Issue: 7
Pages: 963-975
ISSN: 1742-5247 (ISSN-L)
1744-7593
DOI: 10.1517/17425247.2016.1171315
OpenAlex: W2314371091
Cited by: 508
References: 88
Citations by year: 2026: 33 · 2025: 45 · 2024: 63 · 2023: 63 · 2022: 84 · 2021: 64 · 2020: 58 · 2019: 37 · 2018: 29 · 2017: 27 · 2016: 4
FWCI: 2.83
Type: journal article
Language: en
Open access: closed
Locations: Expert Opinion on Drug Delivery (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords: cerebrospinal fluid, blood-brain barrier, brain drug delivery, choroid plexus, blood-CSF barrier, drug transport, bulk flow
MeSH terms: Animals, Biological Transport, Blood-Brain Barrier, Brain, Choroid Plexus, Humans, Drug Delivery Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

CSF, blood-brain barrier, and brain drug delivery

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks